| Previous close | 0.6300 |
| Open | 0.6400 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 33.00 |
| Expiry date | 2024-12-20 |
| Day's range | 0.6200 - 0.6800 |
| Contract range | N/A |
| Volume | |
| Open interest | 178 |
Simply Wall St.Pfizer First Quarter 2024 Earnings: Beats Expectations
Pfizer ( NYSE:PFE ) First Quarter 2024 Results Key Financial Results Revenue: US$14.9b (down 19% from 1Q 2023). Net...
Barrons.comPfizer Is Adding a Wall Street Analyst to Its C-Suite. What He Thinks the Company Needs to Do.
Andrew Baum, the prominent Wall Street drug company analyst will be the pharma firm’s chief strategy and innovation officer.
ZacksInvestors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
© 2024 Yahoo. All rights reserved.